Gerald Crans

Gerald Crans is a Senior Director at Gilead Sciences, where they leverage their extensive expertise in biostatistics and clinical trial design. With a PhD in Statistics from the University of Florida, they have held key positions at various pharmaceutical companies, including Director roles at Elan and FibroGen, and an Associate Director/Director position at Gilead Sciences prior to their current role. Gerald's experience spans multiple therapeutic areas, notably in osteoporosis, Alzheimer's, oncology, liver diseases, and kidney conditions.